# Transcranial Magnetic Stimulation Study of Cortical Excitability as Marker of Antidepressant Response: EXCIPSY Study

> **NCT03606850** · NA · UNKNOWN · sponsor: **Centre Hospitalier du Rouvray** · enrollment: 22 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DEVICE:** Measurements of markers of cortical excitability by TMS

## Key facts

- **NCT ID:** NCT03606850
- **Lead sponsor:** Centre Hospitalier du Rouvray
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-30
- **Primary completion:** 2020-08-30
- **Final completion:** 2020-08-30
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2018-07-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03606850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03606850, "Transcranial Magnetic Stimulation Study of Cortical Excitability as Marker of Antidepressant Response: EXCIPSY Study". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03606850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
